(Press-News.org) Vaccinated patients hospitalized with COVID-19 who developed acute kidney injury had better outcomes than unvaccinated patients with the same condition, new research suggests. The study found vaccinated patients were less likely to stay on dialysis after discharge, and more likely to survive, than unvaccinated patients.
Acute kidney injury, or AKI, is common among people infected with COVID-19, with rates running as high at 46%. It can lead to a mild decrease in kidney function or, if severe enough, to dialysis. The long-term renal and survival outcomes of these patients, however, has not been well understood.
The findings, to be published June 13 in the peer-reviewed journal Kidney Medicine, suggest that COVID-19 vaccination can reduce long-term kidney function decline and mortality risk, said lead author Dr. Niloofar Nobakht, health sciences clinical associate professor of medicine in the division of nephrology at the David Geffen School of Medicine at UCLA.
“The COVID-19 vaccine is an important intervention that can decrease the chances of developing complications from the COVID-19 infection in patients hospitalized with acute kidney injuries,” Nobakht said. “It is important for individuals to discuss the benefits of getting vaccinated for COVID-19 with their doctors as it can decrease the chances of needing dialysis, which can severely affect the quality of life of patients and lead to further complications including death.”
The researchers analyzed about 3500 patients hospitalized with COVID-19 between March 1, 2020 and March 30, 2022. Of those patients, 972 developed acute kidney injury, with 411 (42.3%) unvaccinated and 467 (48%) having received at least two doses of the Pfizer or Moderna mRNA vaccines or one dose of Johnson & Johnson’s vaccine.
They found that 65 (15.8%) unvaccinated patients were more likely to need a type of dialysis for critically ill patients called continuous renal replacement therapy (CRRT) compared with 51 (10.9%) vaccinated patients.
In addition, they also found that unvaccinated patients had 2.56 times the odds of needing CRRT after hospital discharge, 5.54 times the risk of dying in the hospital and 4.78 times higher risk of dying during long-term follow-up compared with vaccinated patients.
Among the study’s limitations, the researchers were missing baseline data for creatinine, which may have contributed to the difference in AKI between the vaccinated and unvaccinated patients. They also lacked data on severity of COVID-19 illness, though they noted that the patients were all ill enough to have required hospitalization. They also did not include the effects of booster vaccinations.
“This study also emphasizes the importance of the need for continued research in understanding how COVID-19 infections affect the kidney and how we should manage and monitor kidney complications from COVID-19 infections to improve patient outcomes,” Nobakht said.
Co-authors are Dr. Charley Jang, Tristan Grogan, Dr. Peter Fahim, Dr. Ira Kurtz, Dr. Joanna Schaenman, Dr. James Wilson, and Dr. Mohammad Kamgar of UCLA.
The study was funded by the National Center for Advancing Translational Science (NCATS) of the National Institutes of Health under the UCLA Clinical and Translational Science Institute (UL1TR001881).
END
Vaccinated patients hospitalized with COVID-linked acute kidney injury less likely to need dialysis, and more likely to survive, after discharge
2025-06-13
ELSE PRESS RELEASES FROM THIS DATE:
What’s driving the rise of NLM wines?
2025-06-13
New research from Adelaide Business School at the University of Adelaide provides a framework for understanding the growing consumer interest in no, low and mid (NLM) alcohol wines.
Dr Hannah Ford’s comprehensive scoping review, published in Journal of Marketing Management , suggests that consumer adoption of NLM wines is influenced by a range of factors, while wine businesses themselves play a pivotal role.
“The global wine industry is evolving rapidly in response to growing health-conscious and moderation-driven drinking trends,” Dr Ford explains. “The review proposes that appeal to NLM wines is influenced ...
Koalas set to benefit from new genetic screening tool
2025-06-13
A University of Queensland-led project has developed a tool to standardise genetic testing of koala populations, providing a significant boost to conservation and recovery efforts.
Dr Lyndal Hulse from UQ’s School of the Environment said the standardised koala genetic marker panel provides a consistent method for researchers nationwide to capture and share koala genetic variation, enabling improved collaboration and data integration across studies.
“Koalas in the wild are under increasing pressure ...
Scientists discover the ‘ticking’ mechanism driving nature’s simplest circadian clock
2025-06-13
Aichi, Japan--Researchers from the Institute for Molecular Science (IMS)/SOKENDAI and Kyushu University have uncovered the molecular mechanism that drives the "ticking" of the circadian clock in cyanobacteria. Their study reveals how a clock protein called KaiC controls chemical reactions with remarkable precision, acting like the hand of a clock that waits, then moves at just the right moment. The findings were published in PNAS Nexus on April 28, 2025.
To adapt to Earth's daily rotation, most living organisms, from simple, single-celled bacteria to complex, multicellular ...
Potential anti-breast cancer drug identified
2025-06-13
A surgeon can excise breast cancer from the body, but even the most skilled scalpel may not be able to remove every cell — especially when the cells have spread from the original disease site elsewhere in the body. This proliferation and migration of breast cancer cells involves many still unknown molecular means, but researchers at Hiroshima University have elucidated at least one mechanism. With the discovery, they may have also uncovered how short chains of protein building blocks could serve as a novel anticancer drug.
The team published their findings on April 9 in the British Journal of Pharmacology. ...
Major review finds 34% reduction in suicide risk following electroconvulsive therapy in patients with severe depression
2025-06-12
A newly published analysis reveals that individuals with severe depression who received electroconvulsive therapy (ECT) were 34% less likely to die by suicide compared to those treated with standard alternatives such as anti-depressant medication. This comprehensive meta-analysis (an analysis pooling and synthesizing previous studies), building on prior research and incorporating the most up-to-date evidence — is the first of its kind to demonstrate such a significant reduction in suicide risk linked to ECT. The findings also show that patients receiving ECT had 30% fewer deaths from any cause, suggesting broader health benefits beyond mental health.
Researchers ...
Doctors urge FIFA to end deal with Coca-Cola ahead of Club World Cup
2025-06-12
Football’s governing body FIFA should drop Coca-Cola as sponsors of the 2025 Club World Cup which begins this week, urge doctors in The BMJ today.
Dr Chris van Tulleken at University College London and Professor Carlos Monteiro at the University of São Paulo, say Coca-Cola and other sugary drinks companies have exploited the world's most popular sport for commercial gain - profiting off players and fans while contributing to a global health crisis.
FIFA now has an opportunity to lead by example and send a powerful message - that health supersedes corporate sponsorship, they write.
As FIFA’s official sponsor since 1978, Coca-Cola has leveraged its massive platform ...
Scientists detect light passing through entire human head, opening new doors for brain imaging
2025-06-12
For decades, scientists have used near-infrared light to study the brain in a noninvasive way. This optical technique, known as "fNIRS" (short for "functional near-infrared spectroscopy"), measures how light is absorbed by blood in the brain, to infer activity. Valued for portability and low cost, fNIRS has a major drawback: it can’t see very deep into the brain. Light typically only reaches the outermost layers of the brain, about 4 centimeters deep—enough to study the surface of the brain, but not deeper ...
Exposure to “forever chemicals” before birth may raise blood pressure during teen years
2025-06-12
Research Highlights:
Being exposed to synthetic compounds called “forever chemicals” before birth was linked to higher systolic (top number) blood pressure in children, especially during their adolescent years.
Compared to other children, the risk of elevated blood pressure was higher among boys and children born to Black mothers with high levels of forever chemicals in their blood around the time of delivery.
The study underscores the importance of reducing exposure to forever chemicals during pregnancy, ...
New study challenges assumptions linking racial attitudes and political identity in U.S. cities
2025-06-12
Nearly 40% of U.S. cities analyzed in a new study in NPJ Complexity diverge from the common narrative that Republican-dominated areas have high levels of implicit racial bias while Democratic strongholds are more tolerant.
Led by Santa Fe Institute Complexity Postdoctoral Fellow Andrew Stier, the study combines prior research on implicit racial bias — people’s unconscious attitudes and beliefs about race — with voting data from the 2016 and 2020 presidential elections across 146 U.S. cities.
Instead ...
Rising T1DE alliance adds Lurie Children’s to further disseminate new data-driven care model for type 1 diabetes
2025-06-12
The Rising T1DE Alliance (Rising T1DE), a national collaborative spearheading innovation in type 1 diabetes care, is transforming how healthcare systems leverage data, technology, and collaboration to drive improved patient outcomes. Launched in 2020 through grant supports from The Leona M. and Harry B. Helmsley Charitable Trust, Rising T1DE’s work is helping shape a future where proactive, integrated, real-time diabetes management becomes the new standard of care. A recent $5.1 million grant from the Helmsley Charitable Trust to Ann & Robert H. Lurie Children’s Hospital of Chicago adds Lurie Children’s to Rising T1DE’s leadership ...